OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002366$7.5657

RongFa Nuclear Equipment Co Ltd

Industrial Machinery & EquipmentVerified

RongFa Nuclear Equipment Co Ltd has a market capitalization of CNY 15.73 billion and a price-to-book ratio of 3.45, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 2.94, suggesting it has sufficient short-term assets to cover its liabilities. However, its operating cash flow is negative at CNY -14.99 million, and free cash flow is also negative at CNY -250.86 million, signaling potential cash flow constraints. Profitability metrics are weak, with a return on equity of -1.78% and a return on assets of -1.04%, both significantly below industry norms. The company reported a net loss of CNY 81.14 million and an operating loss of CNY 116.98 million, reflecting poor operational performance. Gross profit of CNY 9.34 million is minimal compared to revenue of CNY 905.57 million, indicating low margins and potential pricing or cost control issues. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific and regional risks. The capital structure is supported by a debt-to-equity ratio of 0.38, suggesting a relatively conservative leverage profile. However, the company's long-term debt of CNY 1.75 billion and negative net cash position raise concerns about long-term solvency. Looking ahead, the company is expected to face continued challenges. Revenue growth is not projected to improve in the near term, and the operating loss is likely to persist. The capital expenditure of CNY -262.08 million indicates ongoing investment, but without a clear path to profitability, these expenditures may not yield returns. The company's free cash flow is expected to remain negative, limiting its ability to fund operations or return value to shareholders. Risk factors include liquidity constraints, as the company has negative net cash after subtracting total debt. The risk of dilution is currently low, but the company's financial performance and capital structure suggest potential for future dilution if it needs to raise additional capital. The company's recent financial results, including a net loss and negative cash flows, highlight the need for operational improvements and cost management. Recent events, such as the reported net loss and negative cash flows, underscore the company's financial challenges. The company's ability to address these issues will be critical to its long-term viability. The lack of disclosed strategic initiatives or significant operational changes in recent filings suggests that the company may be in a period of stagnation or decline.

30-day price · 002366-0.06 (-0.8%)
Low$6.96High$7.99Close$7.09As of21 May, 00:00 UTC
Profile
CompanyRongFa Nuclear Equipment Co Ltd
Ticker002366.SZ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. RongFa Nuclear Equipment Co Ltd designs, manufactures, and supplies nuclear equipment and related industrial machinery, primarily serving the energy and industrial sectors.

Classification. The company is classified under the Industrial Machinery & Equipment industry within the Industrial Goods business sector, with a confidence level of 0.92.

RongFa Nuclear Equipment Co Ltd has a market capitalization of CNY 15.73 billion and a price-to-book ratio of 3.45, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 2.94, suggesting it has sufficient short-term assets to cover its liabilities. However, its operating cash flow is negative at CNY -14.99 million, and free cash flow is also negative at CNY -250.86 million, signaling potential cash flow constraints. Profitability metrics are weak, with a return on equity of -1.78% and a return on assets of -1.04%, both significantly below industry norms. The company reported a net loss of CNY 81.14 million and an operating loss of CNY 116.98 million, reflecting poor operational performance. Gross profit of CNY 9.34 million is minimal compared to revenue of CNY 905.57 million, indicating low margins and potential pricing or cost control issues. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific and regional risks. The capital structure is supported by a debt-to-equity ratio of 0.38, suggesting a relatively conservative leverage profile. However, the company's long-term debt of CNY 1.75 billion and negative net cash position raise concerns about long-term solvency. Looking ahead, the company is expected to face continued challenges. Revenue growth is not projected to improve in the near term, and the operating loss is likely to persist. The capital expenditure of CNY -262.08 million indicates ongoing investment, but without a clear path to profitability, these expenditures may not yield returns. The company's free cash flow is expected to remain negative, limiting its ability to fund operations or return value to shareholders. Risk factors include liquidity constraints, as the company has negative net cash after subtracting total debt. The risk of dilution is currently low, but the company's financial performance and capital structure suggest potential for future dilution if it needs to raise additional capital. The company's recent financial results, including a net loss and negative cash flows, highlight the need for operational improvements and cost management. Recent events, such as the reported net loss and negative cash flows, underscore the company's financial challenges. The company's ability to address these issues will be critical to its long-term viability. The lack of disclosed strategic initiatives or significant operational changes in recent filings suggests that the company may be in a period of stagnation or decline.
Key takeaways
  • RongFa Nuclear Equipment Co Ltd is trading at a premium to book value, but its weak profitability and negative cash flows raise concerns about its valuation.
  • The company's return on equity and return on assets are significantly below industry norms, indicating poor operational performance.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • The company's liquidity position is medium, with a current ratio of 2.94, but negative operating and free cash flows suggest potential cash flow constraints.
  • The risk of dilution is currently low, but the company's financial performance and capital structure suggest potential for future dilution if it needs to raise additional capital.
  • Recent financial results, including a net loss and negative cash flows, highlight the need for operational improvements and cost management.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$905.6M
Gross profit$9.3M
Operating income-$117.0M
Net income-$81.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$15.0M
CapEx-$262.1M
Free cash flow-$250.9M
Total assets$7.82B
Total liabilities$3.26B
Total equity$4.56B
Cash & equivalents
Long-term debt$1.75B
Valuation
Market price$7.56
Market cap$15.73B
Enterprise value$17.48B
P/E
Reported non-GAAP P/E
EV/Revenue19.3
EV/Op income
EV/OCF
P/B3.5
P/Tangible book3.5
Tangible book$4.56B
Net cash-$1.75B
Current ratio2.9
Debt/Equity0.4
ROA-1.0%
ROE-1.8%
Cash conversion18.0%
CapEx/Revenue-28.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric002366Activity
Op margin-12.9%9.4% medp25 9.4% · p75 9.4%bottom quartile
Net margin-9.0%5.8% medp25 5.8% · p75 5.8%bottom quartile
Gross margin1.0%26.9% medp25 26.9% · p75 26.9%bottom quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-28.9%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity38.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Last actual EPS-0.74 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:13 UTCJob: 35141213